Odyssean LLC’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
Other funds holding TRDA
BBA
Odyssean LLC's TRDA Position: Q3 2026 in Review
Odyssean LLC sold out of Entrada Therapeutics (TRDA) in Q3 2026, closing a stake of 31,305 shares — an estimated $230K sold.
Odyssean LLC first reported a position in TRDA in Q2 2026 and held it in 1 quarter. The position peaked at $230K in Q2 2026. 132 funds tracked by Wall St. Rank hold TRDA as of Q3 2026.
- Odyssean LLC reported no remaining Entrada Therapeutics position as of Q3 2026 after selling out during the quarter.
- Odyssean LLC sold 31,305 Entrada Therapeutics shares in Q3 2026, an estimated $230K.
- Odyssean LLC first reported a position in Entrada Therapeutics in Q2 2026 and held it in 1 quarter.
- Odyssean LLC's Entrada Therapeutics position peaked at $230K in Q2 2026.
- 132 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.